MedPath

Qualitative assessment and evaluation for change of patient oriented QOL regarding long-acting injectable antipsychotics for schizophrenia

Not Applicable
Recruiting
Conditions
schizophrenia
Registration Number
JPRN-UMIN000023445
Lead Sponsor
Department of Neuropsychiatry, Kansai Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Subjects are difficulty in accomplishment of the interview Subjects using antipsychotics 3 or more Subjects who principal investigator decide unsuitable for this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The schedule for the evaluation of individual quality of life-direct weighting (SEIQoL-DW) Interview to patients for using Grounded Theory Approach
Secondary Outcome Measures
NameTimeMethod
Specific level of functioning scale (SLOF) Positive and negative syndrome (PANSS) Drug-Induced extrapyramidal symptoms scale (DIEPSS) Japanese adult reading test (JART) Beck Cognitive Insight Scale(BCIS)
© Copyright 2025. All Rights Reserved by MedPath